MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on May 9, 2008; DOI: 10.1124/mol.108.045146


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.108.045146v1
74/2/485    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gouwy, M.
Right arrow Articles by Van Damme, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gouwy, M.
Right arrow Articles by Van Damme, J.


Received for publication January 11, 2008.
Revised May 9, 2008.
Accepted for publication May 9, 2008.

Synergy between co-produced CC and CXC chemokines in monocyte chemotaxis through receptor mediated events

Mieke Gouwy 1, Sofie Struyf 1, Samuel Noppen 1, Evemie Schutyser 1, Jean-Yves Springael 2, Marc Parmentier 2, Paul Proost 1, Jo Van Damme 1*

1 Rega Institute 2 Institut de Recherche Interdisciplinaire en Biologie Humaine et Moleculaire (IRIBHM)

* Address correspondence to: E-mail: jo.vandamme{at}rega.kuleuven.be

Abstract

CC and CXC chemokines co-induced in fibroblasts and leukocytes by cytokines and microbial agents determine the number of phagocytes infiltrating into inflamed tissues. Interleukin-8/CXCL8 and stromal cell-derived factor-1/CXCL12 significantly and dose-dependently increased the migration of monocytes, expressing the corresponding CXC chemokine receptors CXCR2 and CXCR4, towards suboptimal concentrations of the monocyte chemotactic proteins CCL2 or CCL7. These findings were confirmed using different chemotaxis assays and monocytic THP-1 cells. In contrast, the combination of two CC chemokines (CCL2 plus CCL7) or two CXC chemokines (CXCL8 plus CXCL12) did not provide synergy in monocyte chemotaxis. These data show that chemokines competing for related receptors and using similar signaling pathways do not synergize. Receptor heterodimerization is probably not essential for chemokine synergy as shown in CXCR4/CCR2 co-transfectants. Interestingly, CCL2 mediated extracellular signal-regulated kinase (ERK)1/2 phosphorylation and calcium mobilization was significantly enhanced by CXCL8 in monocytes, indicating cooperative downstream signaling pathways during enhanced chemotaxis. Moreover, in contrast to intact CXCL12, truncated CXCL12(3-68), which has impaired receptor signaling capacity but can still desensitize CXCR4, was not able to synergize with CCL2 in monocytic cell migration. Furthermore, AMD3100 and RS102895, specific CXCR4 and CCR2 inhibitors, respectively, reduced the synergistic effect between CCL2 and CXCL12 significantly. These data indicate that for synergistic interaction between chemokines binding and signaling of the two chemokines via their proper receptor is necessary.


Key words: Chemotactic peptides, Interleukins





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics